Explore how batch variability impacts bioequivalence standards. Learn why the 80-125% rule may be flawed and how new Between-Batch methods improve generic drug safety.
Oct, 22 2025
Apr, 10 2026
May, 14 2026
Jul, 3 2026
Feb, 3 2026